Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-06 Purchase | 2024-02-06 1:08 pm | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 5,000 | $0.98175 | $4,909 | 12,859 (Direct) | View |
| 2022-06-06 Purchase | 2023-02-07 4:53 pm | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 5,000 | $1.411 | $7,055 | 7,859 (Direct) | View |
| 2021-02-09 Purchase | 2021-02-09 3:20 pm | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 1,500 | $20 | $30,000 | 1,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-04 Option Award | 2024-03-06 1:28 pm | N/A 2034-03-03 | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 654,000 | $0 | 235,000 (Direct) | View |
| 2023-02-27 Option Award | 2023-02-28 4:30 pm | N/A 2033-02-26 | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 728,270 | $0 | 728,270 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 9:18 pm | N/A 2032-02-17 | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 630,000 | $0 | 630,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 4:59 pm | N/A 2031-02-03 | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 340,000 | $0 | 340,000 (Direct) | View |
Ownership | 2021-02-04 5:22 pm | N/A 2029-09-06 | Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer | 0 | $0 | 1,069,756 (Direct) | View |